Endovascular Treatment
of Aneurysms

Most aneurysms can now be treated by without the need to approach the aneurysm through an opening in the skull.
This procedure does still require a general anaesthetic in almost all cases to ensure that the head remains absolutely still.
A thin wire is passed though an artery in the groin or arm and navigated up through the main blood vessel of the body
- the aorta. The wire travels past the heart, up through the blood vessels in the neck and into the arteries within the skull
that deliver blood to the brain.

Endovascular Coiling

Tiny metal coils are deployed within the sac of the aneurysm. Originally these coils were made of platinum but endovascular technology is developing all the time and other materials have been introduced to increase the efficacy of the coils. Fundamentally the goal is that a blood clot will develop around the ball of coils which ultimately will create a scar that prevents blood from entering the aneurysm.

Coiling has proven to be a safe and robust treatment for ruptured aneurysms and there are good quality clinical trials demonstrating this over the long term. Most endovascular treatments in the UK are carried out by specialist interventional neuroradiologists. The doctors carrying out your treatment will discuss the procedure, the chances of success and the risks beforehand.

The base of an aneurysm may be so wide that the ball of coils may not be retained within the aneurysm at least in the early stage of their deployment. If the coil ball falls into the blood vessel from which the aneurysm arises it may occlude the vessel causing a stroke. This problem may be solved by using a tiny balloon within the vessel to support the coils inside the aneurysm until they are packed sufficiently tightly and the aneurysm is secure.

Occasionally the base (or neck) of the aneurysm is too wide for even a tightly packed coil ball to remain within the aneurysm. Improvements in materials technology have allowed the development of expandable metal stents which can be placed within the blood vessel to support the coil ball and ensure blood continues to flow through the blood vessels. The animation on the right explains how a stent may be deployed to facilitate the coiling of an aneurysm.

Flow Diverting Stents

A new generation of endovascular devices called flow diverting stents have recently been approved for use. These stents can divert blood from entering an aneurysm sufficiently to occlude it but allow blood flow to continue into branching vessels emerging from the parent vessel which has given rise to the aneurysm. They may also be combined with coil reinforcement of the aneurysmal dome.

An example used regularly in our practice is the Pipeline Embolisation Device (PED) and its deployment is shown in the animation on the left.

Your interventional neuroradiologist and neurosurgeon will be happy to discuss whether your aneurysm would be best treated in this way.

As with all new or emerging technologies there is still much to learn about the limitations as well as the applications of flow diverting stents and their use is still reserved for specific indications in our practice when believed to add safety of efficacy over established treatments. They are often used in conjunction with endovascular coiling.

Woven Endobridge Device (WEB)

Woven Endobridge Device Another family of novel devices are the intra-aneurysmal flow disrupters. The best known of these currently is the Woven Endo Bridge (WEB) device. Devices like this hold out the possibility of endovascularly treating wide necked aneurysm without the need to administer drugs to inhibit blood clotting. However as experienced as accrued with them use of an antiplatelet agent is often reccomended in the early stages after treatment.

This type of technology evolves rapidly and allows treatment options for lesions that sometimes could not be safely treated by other means. However it requires time to be certain that new devices are safe and efficacious once in widespread use.

If a novel device is being considered as part of your treatment in our practice we encourage you to ask questions of us. We will be happy to provide additional written information about novel devices and discuss alternative approaches. Where possible we look to introduce novel devices in the context of a clinical trial or contribute data to registries.